Partner A: $189 for one month. Partner B: $299 for two months. Partner B wins on sticker price.
Until you divide by approximate days of supply and add the same processing and shipping rows. Now Partner A costs less per patient-month, and your membership quote was built on the wrong row.
That is the compound pricing trap clinic ops and telehealth finance leads describe when they ask how much medication is worth for a month, two months of supply and try to compare quotes from different 503A partners on one spreadsheet.
This guide explains why one-month vs two-month supply breaks comparisons, shows a side-by-side worksheet ops teams use before they quote patients, and connects supply-duration math to the broader 503A apples-to-apples comparison framework.
Who this is for
This article is for clinic ops leads, pharmacy coordinators, and founder-led telehealth finance owners who evaluate 503A compounders and set cash-pay member pricing.
You are not the audience if you are a patient comparing monthly injection programs or shopping for the lowest GLP-1 membership. This is coordinator-side economics content only. It is not medical advice.
The scene ops teams describe on vendor calls
On a recent discovery call with a national telehealth team, pricing friction showed up in the same order we hear from scaled weight-loss and hormone brands:
- “Are these base prices?”
- “Shipping fee… processing fee…”
- “How much would it be a month, two months, worth of medication?”
- “We need to compare currently the pricing from our different pharmacy partners.”
They were not asking for a product tour. They needed credible landed math on the same supply duration so they could quote subscribers and pick partners without rebuilding a spreadsheet every quarter.
You cannot compare vial prices if supply duration is not on the same row.
That outcome line maps directly to what breaks when one partner quotes a 28-day vial and another quotes a 56-day vial without labeling days of supply.
Why month vs two-month supply is not a discount tier
Supply duration is how many days one compounded vial is intended to cover at your clinic’s protocol, not a bulk discount label from the pharmacy.
A two-month supply is a different product row than a one-month supply, even when:
- The medication name matches (semaglutide, tirzepatide, etc.)
- The strength and concentration match
- The partner is the same 503A compounder
Treat one-month and two-month as separate SKUs in your comparison chart. Rank them only after you normalize to landed cost per patient-period.
If you skip that step, the cheapest vial on a sales PDF is often the most expensive month once checkout runs.
The comparison table: one-month vs two-month supply rows
Build every partner evaluation with both supply durations on explicit rows, or normalize every quote to the same approximate days before you rank.
This worksheet uses illustrative numbers to show the math, not live market quotes.
| Row | One-month supply (28 days) | Two-month supply (56 days) |
|---|---|---|
| Medication + strength | Semaglutide 2.5 mg/mL | Semaglutide 2.5 mg/mL |
| Concentration / package | 1 mL vial | 2 mL vial |
| Approximate days of supply | 28 days | 56 days |
| Base medication price | $165 | $299 |
| Facilitation / platform fee | $8 (disclosed) | $8 (disclosed) |
| Processing | $12 | $12 |
| Shipping | $29 flat | $29 flat |
| Estimated landed cost (one vial) | $214 | $348 |
| Landed cost per 28 days | $214 | $174 |
Read that last row twice. The two-month vial looked more expensive on sticker price ($348 vs $214). Normalized to the same 28-day patient-period, it is cheaper per month ($174 vs $214).
Without the days of supply row, a coordinator ranks Partner B as “more expensive” and quotes members from the wrong COGS layer.
When the ranking flips the other way
Two-month supply does not always win per patient-month. Fees that hit once per order can erase bulk-duration savings.
| Row | One-month supply (28 days) | Two-month supply (56 days) |
|---|---|---|
| Base medication price | $149 | $265 |
| Processing | $12 | $12 |
| Shipping (zone surcharge) | $29 | $45 |
| Estimated landed cost | $190 | $322 |
| Landed cost per 28 days | $190 | $161 |
Here the two-month row still wins per 28 days, but the margin is thinner than base price alone suggests because shipping stepped up on the larger package.
Ops teams that compare base medication price only miss that row entirely.
How to normalize supply duration (three steps)
Use this workflow before you reset member pricing or sign a new 503A partner. Full column definitions live in the apples-to-apples 503A pricing guide.
1. Lock strength and concentration.
2.5 mg/mL and 5 mg/mL are not interchangeable even when the drug name matches.
2. State approximate days of supply on every row.
If a rep says “two months,” ask what day count their catalog uses (28, 30, 56, 60). Write it down on the chart.
3. Divide landed cost by days, then multiply to your standard period.
Landed cost per 28 days = (estimated landed cost / approximate days of supply) × 28Run the math on estimated landed cost, not base medication price. Processing and shipping belong in the numerator.
For semaglutide-specific COGS definitions, see landed cost per vial.
Five ways supply duration breaks partner comparisons
1. Mixing one-month and two-month rows without a days column.
The most common spreadsheet failure. Every partner column needs approximate days of supply beside base price.
2. Assuming two-month means half the monthly cost.
Bulk-duration vials save coordinator time, not automatically 50 percent on COGS. Fees and shipping still apply once per vial.
3. Quoting members from the wrong duration.
If your program bills monthly but your COGS row is a 56-day vial, membership margin drifts every refill cycle.
4. Ignoring SIG and titration step.
A “two-month” vial at one titration step may cover fewer calendar days when the prescriber advances dose mid-cycle. Ops should confirm days of supply at the step you actually order, not a generic catalog label.
5. Catalog price that hides duration.
Some portals show a vial price without approximate days of supply on the browse row. Coordinators discover duration only at checkout or on the invoice.
Pass-through pricing puts landed cost and supply context on the catalog row so the comparison chart matches what coordinators see before they add a patient line.
Questions to ask every 503A partner about supply duration
Add these to demo and reference calls:
- What approximate days of supply does this vial cover at our protocol?
- Is the catalog row one month or two months of medication?
- Do processing and shipping change when we order a larger vial?
- Does price at catalog browse match price at checkout for the same duration?
- Can you export the same strength and days of supply we order today for a comparison chart?
If answers shift between browse and checkout, your month-vs-two-month math is building on sand.
How supply duration connects to member pricing
Cash-pay clinics and telehealth brands set membership or per-fill pricing from COGS plus margin. When COGS rows mix durations, teams pad quotes “to be safe” and lose deals, or underprice and eat margin on every refill.
The outcome ops buyers name on calls is simple: quote patients from landed cost you trust on the same strength and supply duration before checkout, not invoice archaeology after the order ships.
Field teams rank pricing transparency alongside support quality. A partner you cannot compare on patient-month economics is a partner you cannot defend to your CFO or your members.
Wrong duration math costs more than a slow vendor decision. It ships incorrect member pricing to thousands of subscribers before anyone notices the spreadsheet error.
Where Fizy Health fits (honest framing)
Fizy Health is built for clinics that already use 503A compounders and need one ordering layer with economics you can see before you commit.
Pass-through pricing shows resolved per-vial 503A cost in the medication catalog with strength and supply context on every row. Checkout separates drug cost from disclosed facilitation before card authorization, so your one-month vs two-month worksheet matches what coordinators see on screen.
That is the proof behind the outcome: landed cost per patient-period on the same strength and supply duration before you quote.
Telehealth-specific context lives on the telehealth ops page. For the full nine-column partner chart, use the 503A apples-to-apples guide. For semaglutide COGS definitions, see landed cost per vial.
Bottom line
You cannot compare compound pharmacy partners when one quote is a one-month vial and another is two months on a different row. Lock strength, label approximate days of supply, add every fee, and rank landed cost per patient-period.
Build the chart before you quote members. The cheaper two-month sticker is not always the cheaper month once fees and normalization run.